Clinical trials
Terminated Phase 3 trials in Lebanon
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 2 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2017 | 3 |
| 2018 | 5 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 28 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 8 |
| Pfizer | 4 |
| American University of Beirut Medical Center | 3 |
| Shire | 3 |
| AB Science | 1 |
| Anthera Pharmaceuticals | 1 |
| Areteia Therapeutics | 1 |
| AstraZeneca | 1 |
| BioCryst Pharmaceuticals | 1 |
| Eli Lilly and Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia, Sickle Cell | 6 |
| Neoplasm Metastasis | 4 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Vaso-Occlusive Crises | 3 |
| Asthma | 2 |
| Crohn Disease | 2 |
| Hematologic Diseases | 2 |
| Acute Coronary Syndrome | 1 |
| Breast Neoplasms | 1 |
| Carcinoma | 1 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.